Text Size

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

This study has been completed.
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00376610
First received: September 14, 2006
Last updated: July 3, 2007
Last verified: July 2007
History of Changes
  Purpose

ASR/Re-cap versus 28 MoM


Condition Intervention Phase
Bearings
 Device: ASR/Re-cap
 Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics/Dynamics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00376610

Locations
Denmark
Frederiksberg University Hospital
Frederiksberg, Copenhagen, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00376610     History of Changes
Other Study ID Numbers: KF1127957
Study First Received: September 14, 2006
Last Updated: July 3, 2007
Health Authority: Denmark: De Videnskabsetiske Komit'eer for Københavns og Frederiksberg Kommune

ClinicalTrials.gov processed this record on June 18, 2013